Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

被引：22
|
作者：
Walter, Eva [1 ]
Schmitt, Thomas [1 ]
Dietrich, Sascha [1 ]
Ho, Anthony [1 ]
Witzens-Harig, Mathias [1 ]
机构：
[1] Univ Heidelberg, Dept Internal Med 5, D-69120 Heidelberg, Germany
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 11期
关键词：
NON-HODGKINS-LYMPHOMA; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; PLUS RITUXIMAB; PHASE-II; MULTICENTER; OLDER; CHOP;
D O I：
10.3109/10428194.2012.682311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2290 / 2292
页数：3
相关论文
共 50 条
  • [1] Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
    Micallef, Ivana N. M.
    Maurer, Matthew J.
    Wiseman, Gregory A.
    Nikcevich, Daniel A.
    Kurtin, Paul J.
    Cannon, Michael W.
    Perez, Domingo G.
    Soori, Gamini S.
    Link, Brian K.
    Habermann, Thomas M.
    Witzig, Thomas E.
    BLOOD, 2011, 118 (15) : 4053 - 4061
  • [2] Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma
    Roschewski, Mark
    Dunleavy, Kieron
    Wilson, Wyndham H.
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2428 - 2437
  • [3] Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
    Candelaria, Myrna
    Duenas-Gonzalez, Alfonso
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [4] Addition of venetoclax to rituximab cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large cell B lymphoma
    Calleja, Anne
    HEMATOLOGIE, 2021, 27 (02): : 45 - 46
  • [5] Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
    Vitolo, Umberto
    Trneny, Marek
    Belada, David
    Burke, John M.
    Carella, Angelo Michele
    Chua, Neil
    Abrisqueta, Pau
    Demeter, Judit
    Flinn, Ian
    Hong, Xiaonan
    Kim, Won Seog
    Pinto, Antonio
    Shi, Yuan-Kai
    Tatsumi, Yoichi
    Oestergaard, Mikkel Z.
    Wenger, Michael
    Fingerle-Rowson, Gunter
    Catalani, Olivier
    Nielsen, Tina
    Martelli, Maurizio
    Sehn, Laurie H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3529 - +
  • [6] A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma
    Micallef, Ivana N. M.
    Kahl, Brad S.
    Maurer, Matthew J.
    Dogan, Ahmet
    Ansell, Stephen M.
    Colgan, Joseph P.
    Geyer, Susan
    Inwards, David J.
    White, William L.
    Habermann, Thomas M.
    CANCER, 2006, 107 (12) : 2826 - 2832
  • [7] The POLARIX Study: Polatuzumab Vedotin With Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone vs Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 10 - 11
  • [8] Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
    Go, Se-Il
    Park, Mi Jung
    Song, Haa-Na
    Kim, Hoon-Gu
    Kang, Myoung Hee
    Lee, Hyang Rae
    Kim, Yire
    Kim, Rock Bum
    Lee, Soon Il
    Lee, Gyeong-Won
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (05) : 567 - 576
  • [9] Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone
    Hui, David
    Proctor, Bradley
    Donaldson, Jane
    Shenkier, Tamara
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry
    Chhanabhai, Mukesh
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1658 - 1667
  • [10] Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma
    Gao, Yuhuan
    Xie, Yan
    Liu, Lihong
    Xue, Hongwei
    Hou, Ming
    Zhang, Mingzhi
    Zhou, Zeping
    Guo, Pengxiang
    Yao, Hongxia
    Shao, Zonghong
    Xie, Xiaobao
    Zhu, Jun
    MINERVA MEDICA, 2021, 112 (02) : 310 - 312
12345